| Net loss | -23.33M |
| Depreciation and amortization | 9.84M |
| Deferred income taxes | -14.4M |
| Stock based compensation expense | 2.28M |
| Trading securities | 0 |
| Accounts receivable, less allowances | -57.92M |
| Inventories | -55.99M |
| Prepaid expenses | 2.12M |
| Accounts payable | 58.88M |
| Accrued expenses | 3.51M |
| Income taxes | 3.42M |
| Net cash provided by (used in)operating activities | |
| Purchases of property and equipment | -10.81M |
| Net cash used in investing activities | |
| Proceeds from short-term borrowings | |
| Payments on short-term borrowings | |
| Proceeds from issuance of common stock | 0 |
| Tax benefit from stock based awards | |
| Repurchase of common stock | 0 |
| Net cash used in financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | -10K |
| Net increase (decrease) in cash and cash equivalents | -8.58M |
| Cash and cash equivalents at beginning of period | 17.73M |
| Cash and cash equivalents at end of period | 9.15M |
| Income taxes | 64K |
| Interest | 669K |